This inventor holds 47 USPTO granted patents and 10 published patent applications and 20 EPO patents, primarily in Histone Demethylase Inhibitors. Top assignees: Celgene Quanticel Research, Inc., Takeda Pharmaceutical Company Limited, Quanticel Pharmaceuticals, Inc.. Active years: 2009-2024.
Location History:
- San Deigo, CA (US) (2013)
- South San Francisco, CA (US) (2023)
- San Diego, CA (US) (2009 - 2024)
Company Filing History:
31 out of 108 
7 out of 1,226 
5 out of 10 
Years Active: 2009-2024
Areas of Expertise:
Title: The Innovative Work of Zhe Nie in Therapeutic Compounds
Introduction
Zhe Nie, located in San Diego, California, is a distinguished inventor with an impressive portfolio of 47 patents. His work primarily focuses on the development of novel compounds aimed at addressing critical health conditions. Nie's innovative contributions to medicinal chemistry have positioned him as a notable figure in the pharmaceutical industry.
Latest Patents
One of Zhe Nie's latest patents revolves around "Compounds and compositions for treating conditions associated with APJ receptor activity". This disclosure introduces various chemical entities, including pharmacologically acceptable salts and prodrugs, that modulate the apelin receptor (APJ receptor). These compounds are pivotal for treating disorders where a decrease in APJ receptor activity is implicated, such as cardiovascular diseases, metabolic disorders, and infections. Specific conditions addressed include pulmonary hypertension, heart failure, type II diabetes, and renal failure.
Another significant patent by Nie involves "Histone demethylase inhibitors". This innovation provides substituted triazolylpyridine derivative compounds that modulate histone demethylase enzymes. These compounds have potential applications in the treatment of cancer and other diseases associated with abnormal histone demethylase activity, positioning them as vital tools in modern oncology.
Career Highlights
Throughout his career, Zhe Nie has contributed to prominent companies in the pharmaceutical realm, including Celgene, Quanticel Research, Inc., and Takeda Pharmaceutical Company Limited. His extensive experience in these organizations has further enhanced his capabilities in drug discovery and development.
Collaborations
In his journey, Zhe Nie has collaborated with talented professionals such as Jeffrey Alan Stafford and James Marvin Veal. These collaborations have fostered an environment of creativity and innovation, leading to the successful commercialization of breakthrough therapeutics.
Conclusion
Zhe Nie's commitment to advancing medical science through innovative compounds is evident in his extensive patent portfolio and collaborations. His work continues to have a profound impact on the treatment of diseases, underlining the importance of ongoing research and development in the field of pharmacology.